The story has been amended to update the number of bacterial, fungal, and viral respiratory pathogens detected by IDbyDNA's technology.

NEW YORK (GenomeWeb) – IDbyDNA announced today that it has signed a licensing agreement with Brazil-based Fleury Group to offer IDbyDNA's Explify platform for clinical metagenomic testing in South America.